Deepverge PLC
LSE:DVRG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Landing International Development Ltd
HKEX:582
|
HK |
|
Hanjin Kal
KRX:180640
|
KR |
|
T
|
TenX Keane Acquisition
NASDAQ:TENK
|
US |
|
Focus Impact BH3 Acquisition Co
OTC:BHAC
|
US |
|
M
|
Mitsubishi Estate Logistics REIT Investment Corp
TSE:3481
|
JP |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IE |
|
Deepverge PLC
LSE:DVRG
|
1.1m GBP |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
932.9B USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.9B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
134B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
34.6B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
292.7B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.2B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
29.2B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.9B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.7B USD |
Loading...
|
Market Distribution
| Min | -37.7% |
| 30th Percentile | 19.3% |
| Median | 32% |
| 70th Percentile | 38.1% |
| Max | 1 012% |
Other Profitability Ratios
Deepverge PLC
Glance View
DeepVerge Plc is a personal health company, which engages in the development and commercialization of technology and products for the human integumentary system. The company is headquartered in Malahide, Dublin. The company went IPO on 2017-04-05. The firm provides core skin and human testing technology. Its is engaged in collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science. Its collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple partner technologies.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Deepverge PLC’s Gross Margin has decreased from 73.1% to 58.4%. During this period, it reached a low of 41.1% on Dec 31, 2020 and a high of 73.1% on Dec 1, 2019.
